About the Company
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition (for repricing), manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients (APIs), primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PRGO News
Esteve Healthcare To Buy Perrigo's HRA Pharma Rare Diseases Business For Up To EUR 275 Mln
Perrigo Company plc (PRGO), a provider of Consumer Self-Care Products, Thursday said pharmaceutical company Esteve Healthcare, S.L.
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
2024 /PRNewswire/ -- Perrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care ...
Here’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” first quarter 2024 investor ...
Perrigo Co PLC PRGO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Perrigo Company plc (PRGO) Stock Experiences -1.35% Monthly Change
PRGO stock has gone down by -7.01%, with a monthly decline of -1.35% and a quarterly plunge of -9.21%. The volatility ratio for the week is 2.37%, and the volatility levels for the last 30 days are 2.
Perrigo Company plc
Analysts say these cheap stocks have plenty of upside.
Perrigo Company plc: Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
Proposed Divestment of Branded Prescription Pharma Business Further Supports Perrigo's Strategic Focus on Consumer Self-Care Total Purchase Consideration of up to €275 Million, Consisting of €190 Mill ...
Perrigo Co PLC PRGO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Here’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1
Heartland Mid Cap Value Fund featured stocks like Perrigo Company plc (NYSE:PRGO) in the Q1 2024 investor letter. Headquartered in Dublin, Ireland, Perrigo Company plc (NYSE:PRGO) provides over ...
Loading the latest forecasts...